Overview of the EGFR pathway and downstream signaling pathways,... | Download Scientific Diagram
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
EGFR | Cancer Genetics Web
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
APMG Colon Molecular Pathways
IJMS | Free Full-Text | Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
New combination therapy offers bowel cancer patients extra treatment option
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - ScienceDirect
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Frontiers | The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution - ScienceDirect
Biomarqueurs des cancers colorectaux utiles en pratique clinique – FMC-HGE
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Different EGFR signalling pathways induced by the interaction between... | Download Scientific Diagram
Cancers | Free Full-Text | Immune Resistance and EGFR Antagonists in Colorectal Cancer
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Hexameric procyanidins inhibit colorectal cancer cell growth through both redox and non-redox regulation of the epidermal growth factor signaling pathway - ScienceDirect
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Mechanisms of resistance to EGFR inhibitors in colorectal cancers | Colorectal Cancer
Epidermal growth factor receptor (EGFR)-related signaling pathway in... | Download Scientific Diagram
Les biomarqueurs prédictifs dans le cancer colorectal
Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer
Frontiers | The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
The Role of the Epidermal Growth Factor Receptor in the Mechanism and Treatment of Colorectal Cancer - Nirit Yarom - Discovery Medicine
Frontiers | Targeting EGFR in Esophagogastric Cancer
